Auspex Pharmaceuticals is a cutting edge, privately held company devoted to providing elegant and effective solutions to long standing human healthcare issues. We strive to set the future standards of modern drug discovery. Our proprietary scientific platform and our innovative management style are our key assets.
We have set out to discover, develop and market new classes of small molecule therapeutics for the treatment of diseases with large unmet medical needs. We use our in-house expertise to modify existing drugs with non-optimal chemo-physiological properties into novel and proprietary drug candidates. Our disease targets have been selected from the fields of cancer, central nervous system, infectious diseases, skin disorders and diabetes, which represent a combined market of $40bn. Our primary focus is on generics or drugs with pending patent expiration dates. Our goal is to effectively reduce the investment risks associated with the development and marketing of a novel drug while providing the consumer with an improved product.
Given our unique approach and the broad opportunity it presents, we have established ourselves as a fully integrated small pharmaceutical company. With this goal in mind, Auspex has already assembled the nucleus of a world class scientific team. Our experts have over thirty years of experience in early drug discovery and late stage drug development.
